ArticleBMJ open2020

NTNU intranasal naloxone trial (NINA-1) study protocol for a double-blind, double-dummy, non-inferiority randomised controlled trial comparing intranasal 1.4 mg to intramuscular 0.8 mg naloxone for prehospital use.

Arne Kristian Skulberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.